Breaking News Instant updates and real-time market news.

SFIX

Stitch Fix

$28.10

-0.835 (-2.89%)

06:48
07/12/19
07/12
06:48
07/12/19
06:48

Stitch Fix upgraded to Buy from Neutral at Goldman Sachs

Goldman Sachs analyst Heath Terry upgraded Stitch Fix to Buy from Neutral with an unchanged price target of $38. The analyst sees a "more compelling" risk/reward in the company's ability to "lean into" its existing core customer base while also "efficiently" expanding to new categories and geographies. Recent developments in product that enable existing users to order additional colors, prints, and sizes of items they have already purchased should be a tailwind for Stitch Fix's wallet share, Terry tells investors in a research note.

SFIX Stitch Fix
$28.10

-0.835 (-2.89%)

06/06/19
JPMS
06/06/19
NO CHANGE
Target $34
JPMS
Neutral
Stitch Fix price target raised to $34 from $30 at JPMorgan
JPMorgan analyst Doug Anmuth raised his price target for Stitch Fix to $34 from $30 citing the company's "strong" fiscal Q3 results with accelerating revenue growth. The analyst came away from the results more positive on Stitch Fix, saying management continues to execute well, with revenue accelerating each of the past three quarters. However, he'd still like to see a few quarters of stable Active Client growth, which he points out decelerated for the fifth straight quarter. Anmuth keeps a Neutral rating on Stitch Fix.
06/06/19
RHCO
06/06/19
NO CHANGE
Target $44
RHCO
Buy
Stitch Fix price target raised to $44 at SunTrust after 'strong' Q3 results
SunTrust analyst Youssef Squali nudged his price target on Stitch Fix higher to $44 from $43 and kept his Buy rating after its "strong" Q3 results and Q4 guidance. The analyst cites the company's improved existing customer retention along with a "healthy" growth of new active clients and believes that the management's raised outlook is "sustainable". Squali further points to the high percentage of short interest in Stitch Fix float that should drive its shares higher in the short term and its continued margin expansion supporting the stock over the longer run.
07/01/19
NEED
07/01/19
INITIATION
NEED
Hold
Stitch Fix initiated with a Hold at Needham
Needham analyst Rick Patel started Stitch Fix with a Hold rating and no price target. There's a lot to like about the company but expectations have risen following the recent stock rally and visibility on U.K. investment spend is low, Patel tells investors in a research note. As a result, the analyst prefers to wait for a better entry point or greater conviction on the potential for upside to estimates.
07/02/19
RBCM
07/02/19
NO CHANGE
Target $43
RBCM
Outperform
Stitch Fix price target lowered to $43 from $52 at RBC Capital
RBC Capital analyst Mark Mahaney lowered his price target for Stitch Fix (SFIX) to $43 from $52 and reiterated a Market Outperform rating. In a research note to investors, the analyst says is he incrementally positive on Stitch Fix following his firm's second survey of over 2,000 consumers, including around 150 Stitch Fix customers, saying there appears to be growing interest in Online clothing subscription services and the two services within this category that are most frequently used are Amazon Wardrobe (AMZN) and Stitch Fix. While the survey results are positive for Stitch Fix, Mahaney says they also clearly highlihgt the competitive risk of Amazon.

TODAY'S FREE FLY STORIES

MRNS

Marinus Pharmaceuticals

$3.99

0.11 (2.84%)

07:45
07/23/19
07/23
07:45
07/23/19
07:45
Hot Stocks
Marinus Pharmaceuticals announces data from Phase 2 Amaryllis study »

The Amaryllis Study…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRNS

Marinus Pharmaceuticals

$3.99

0.11 (2.84%)

07:44
07/23/19
07/23
07:44
07/23/19
07:44
Hot Stocks
Marinus Pharmaceuticals announces data from Phase 2 Magnolia clinical trial »

Marinus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDNS

Cadence Design

$72.68

-0.21 (-0.29%)

07:43
07/23/19
07/23
07:43
07/23/19
07:43
Recommendations
Cadence Design analyst commentary  »

Cadence Design price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITRI

Itron

$60.62

0.77 (1.29%)

07:43
07/23/19
07/23
07:43
07/23/19
07:43
Recommendations
Itron analyst commentary  »

Canaccord sees several…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Aug

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:41
07/23/19
07/23
07:41
07/23/19
07:41
Hot Stocks
RedHill Biopharma continues to enroll patients in Phase 2a study of YELIVA »

The ongoing Phase 2a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

FBP

First BanCorp

$10.74

-0.25 (-2.27%)

07:40
07/23/19
07/23
07:40
07/23/19
07:40
Earnings
First BanCorp reports Q2 EPS 19c, consensus 19c »

Reports Q2 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:40
07/23/19
07/23
07:40
07/23/19
07:40
Hot Stocks
RedHill Biopharma 'working toward' confirmatory Phase 3 study for BEKINDA »

RedHill is currently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

07:40
07/23/19
07/23
07:40
07/23/19
07:40
General news
Treasury Market Outlook: Treasury yields are modestly cheaper »

Treasury Market Outlook:…

ATI

Allegheny Technologies

$25.11

-0.175 (-0.69%)

07:39
07/23/19
07/23
07:39
07/23/19
07:39
Earnings
Allegheny Technologies reports Q2 ex-items EPS 40c, consensus 34c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:39
07/23/19
07/23
07:39
07/23/19
07:39
Hot Stocks
RedHill Biopharma to initiate Phase 3 study activities with RHB-204 in Q4 »

RedHill plans to initiate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

NOW

ServiceNow

$293.30

3.48 (1.20%)

07:39
07/23/19
07/23
07:39
07/23/19
07:39
Recommendations
ServiceNow analyst commentary at Needham »

ServiceNow price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:39
07/23/19
07/23
07:39
07/23/19
07:39
Hot Stocks
RedHill Biopharma says FDA meetings for RHB-104 to take place in 2H198 »

FDA meetings are planned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:38
07/23/19
07/23
07:38
07/23/19
07:38
Hot Stocks
RedHill Biopharma plans U.S. launch of Talicia in 4Q19 »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

CR

Crane

$86.50

0.99 (1.16%)

, CIR

Circor

$39.83

1.17 (3.03%)

07:37
07/23/19
07/23
07:37
07/23/19
07:37
Recommendations
Crane, Circor analyst commentary  »

Crane Q2 highlighted by…

CR

Crane

$86.50

0.99 (1.16%)

CIR

Circor

$39.83

1.17 (3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 01

    Aug

  • 09

    Sep

  • 09

    Sep

RLGY

Realogy

$5.17

-0.08 (-1.52%)

, AMZN

Amazon.com

$1,985.93

21.15 (1.08%)

07:37
07/23/19
07/23
07:37
07/23/19
07:37
Hot Stocks
Realogy launches TurnKey in collaboration with Amazon »

Realogy (RLGY) announced…

RLGY

Realogy

$5.17

-0.08 (-1.52%)

AMZN

Amazon.com

$1,985.93

21.15 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 08

    Aug

AN

AutoNation

$42.01

-0.045 (-0.11%)

07:36
07/23/19
07/23
07:36
07/23/19
07:36
Recommendations
AutoNation analyst commentary  »

Stephens 'not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 13

    Nov

MYOV

Myovant Sciences

$8.15

-0.25 (-2.98%)

07:36
07/23/19
07/23
07:36
07/23/19
07:36
Hot Stocks
Myovant Sciences says primary efficacy endpoint met in LIBERTY 2 study »

Myovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

07:36
07/23/19
07/23
07:36
07/23/19
07:36
Earnings
Kimberly-Clark sees FY19 net sales flat to down 1% y/y, consensus $18.41B »

Prior assumption was down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

FB

Facebook

$202.32

3.94 (1.99%)

07:35
07/23/19
07/23
07:35
07/23/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

ARAY

Accuray

$3.91

-0.07 (-1.76%)

07:34
07/23/19
07/23
07:34
07/23/19
07:34
Hot Stocks
CNNC Accuray Medical Technology receives safety license in China »

Accuray provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

CYTK

Cytokinetics

$11.65

0.49 (4.39%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

07:34
07/23/19
07/23
07:34
07/23/19
07:34
Hot Stocks
Cytokinetics granted European orphan designation for reldesemtiv »

Cytokinetics Incorporated…

CYTK

Cytokinetics

$11.65

0.49 (4.39%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Hot Stocks
Kimberly-Clark CEO says 'we made excellent progress in the second quarter' »

CEO Mike Hsu said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LECO

Lincoln Electric

$85.18

0.39 (0.46%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Earnings
Lincoln Electric reports Q2 adjusted EPS $1.28, consensus $1.27 »

Reports Q2 revenue $777M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

LMT

Lockheed Martin

$357.57

0.675 (0.19%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Earnings
Lockheed Martin raises FY19 EPS view to $20.85-$21.15 from $20.05-$20.35 »

Consensus is $20.57.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

INGR

Ingredion

$80.40

-0.705 (-0.87%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Recommendations
Ingredion analyst commentary  »

Ingredion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 22

    Aug

  • 19

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.